Testimonials - CureYourOwnCancer.org

Testimonials - CureYourOwnCancer.org

Cannabis Cures - Full Documentary

Dennis Hill- a Bio chemist kills his Prostate cancer using cannabis oil ...

Published on Dec 5, 2012

Dennis Hill,kills his Prostate cancer cells using cannabis oi "Rick Simpson oil" talks about endo-canabinoid system. CBD
Anyone who is interested in or has cancer should listen and learn more about the medicinal affects of cannabis/marijuana

PLOS ONE: Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells

PLOS ONE: Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells

Cannabinoids Induce Pancreatic {beta}-Cell Death by Directly Inhibiting Insulin Receptor Activation -- Kim et al. 5 (216): ra23 -- Science Signaling

Cannabinoids Induce Pancreatic {beta}-Cell Death by Directly Inhibiting Insulin Receptor Activation -- Kim et al. 5 (216): ra23 -- Science Signaling

Cannabinoids Induce Pancreatic {beta}-Cell Death by Directly Inhibiting Insulin Receptor Activation --  5 (216): ra23

Towards the use of cannabinoids as antitumour agents : Abstract : Nature Reviews Cancer

Towards the use of cannabinoids as antitumour agents : Abstract : Nature Reviews Cancer

Nature Reviews Cancer 12, 436-444 (June 2012) | doi:10.1038/nrc3247

Opinion: Towards the use of cannabinoids as antitumour agents

Guillermo Velasco^1,2,3, Cristina Sánchez¹ & Manuel Guzmán^1,2,4  About the authors

Top of page

Abstract

Various reports have shown that cannabinoids (the active components of marijuana and their derivatives) can reduce tumour growth and progression in animal models of cancer, in addition to their well-known palliative effects on some cancer-associated symptoms. This Opinion article discusses our current understanding of cannabinoids as antitumour agents, focusing on recent insights into the molecular mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches. Such knowledge is required for the optimization of preclinical cannabinoid-based therapies and for the preliminary clinical testing that is currently underway.

Top of page

Author affiliations

1. Guillermo Velasco, Cristina Sánchez and Manuel Guzmán are at the Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, and the Instituto Universitario de Investigación Neuroquímica (IUIN), Madrid 28040, Spain.
2. Guillermo Velasco and Manuel Guzmán are also at the Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid 28040, Spain.
3. Guillermo Velasco is also at the Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid 28040, Spain.
4. Manuel Guzmán is also at the Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28040, Spain.

Correspondence to: Guillermo Velasco^1,2,3 Email: gvd@bbm1.ucm.es

Published online 4 May 2012

cannabinoids+their role in glioma pathobiology..Cannabinoids are currently considered as anti-cancer agents

Glioma Signaling - Jolanta Barańska - Google Books

Glioma Signaling - Jolanta Barańska - Google Books